US EditionFDA uncovers ‘significant’ data falsification by Indian company, rejects all studies
Summary by sciencechronicle.in
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
FDA uncovers ‘significant’ data falsification by Indian company, rejects all studies
FDA has said that the Mumbai-based Raptim Research has been “responsible for the creation of false in vitro study data” The U.S. Food and Drug Administration (FDA) has notified an unspecified number of drug companies that data from all in vitro bioequivalence studies conducted by the Navi Mumbai-based contract research organisation (CRO) Raptim Research Ltd … Continue reading FDA uncovers ‘significant’ data falsification by Indian company, rejec…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
